Trials / Terminated
TerminatedNCT04514406
APERTO CVS PMCF Study
APERTO CVS PMCF Study: Drug Coated High Pressure Balloon in Large Veins (re)Stenosis in Dialysis Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Cardionovum GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective Observational Single Arm study aimed to assess safety and effectiveness of APERTO OTW DCB in treating stenosis and restenosis of central veins in dialysis patients
Detailed description
The APERTO CVS PMCF study is aimed to evaluate safety and effectiveness of treatment of central veins (re)stenosis in dialysis patients at short and mid-term follow up, after treatment with APERTO OTW DCB. Primary endpoint will consist in evaluating the intervention free period for patients treated with APERTO OTW. APERTO CVS PMCF Study will also collect data for post-market clinical follow up (PMCF) in a CE mark device used according to intended use
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | APERTO OTW DCB | Drug Coated Balloon Angioplasty |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2020-08-17
- Last updated
- 2024-02-07
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04514406. Inclusion in this directory is not an endorsement.